BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15889140)

  • 1. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.
    Yuasa H; Oike Y; Iwama A; Nishikata I; Sugiyama D; Perkins A; Mucenski ML; Suda T; Morishita K
    EMBO J; 2005 Jun; 24(11):1976-87. PubMed ID: 15889140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity.
    Kataoka K; Sato T; Yoshimi A; Goyama S; Tsuruta T; Kobayashi H; Shimabe M; Arai S; Nakagawa M; Imai Y; Kumano K; Kumagai K; Kubota N; Kadowaki T; Kurokawa M
    J Exp Med; 2011 Nov; 208(12):2403-16. PubMed ID: 22084405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects.
    Bard-Chapeau EA; Szumska D; Jacob B; Chua BQ; Chatterjee GC; Zhang Y; Ward JM; Urun F; Kinameri E; Vincent SD; Ahmed S; Bhattacharya S; Osato M; Perkins AS; Moore AW; Jenkins NA; Copeland NG
    PLoS One; 2014; 9(2):e89397. PubMed ID: 24586749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1.
    Fukuda S; Hoggatt J; Singh P; Abe M; Speth JM; Hu P; Conway EM; Nucifora G; Yamaguchi S; Pelus LM
    Leukemia; 2015 Feb; 29(2):433-40. PubMed ID: 24903482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression.
    Ohyashiki JH; Ohyashiki K; Shimamoto T; Kawakubo K; Fujimura T; Nakazawa S; Toyama K
    Blood; 1995 Jun; 85(12):3713-8. PubMed ID: 7780155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI1 in leukemia and myelodysplastic syndromes.
    Ohyashiki K; Ohyashiki JH; Shimamoto T; Toyama K
    Leuk Lymphoma; 1996 Nov; 23(5-6):431-6. PubMed ID: 9031072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation.
    Tsai FY; Orkin SH
    Blood; 1997 May; 89(10):3636-43. PubMed ID: 9160668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
    Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD
    Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56.
    Saito Y; Kaneda K; Suekane A; Ichihara E; Nakahata S; Yamakawa N; Nagai K; Mizuno N; Kogawa K; Miura I; Itoh H; Morishita K
    Leukemia; 2013 Aug; 27(8):1637-49. PubMed ID: 23478665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.
    Sayadi A; Jeyakani J; Seet SH; Wei CL; Bourque G; Bard FA; Jenkins NA; Copeland NG; Bard-Chapeau EA
    Oncogene; 2016 May; 35(18):2311-21. PubMed ID: 26234679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1.
    Laricchia-Robbio L; Nucifora G
    Blood Cells Mol Dis; 2008; 40(2):141-7. PubMed ID: 17913523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2.
    Gómez-Benito M; Conchillo A; García MA; Vázquez I; Maicas M; Vicente C; Cristobal I; Marcotegui N; García-Ortí L; Bandrés E; Calasanz MJ; Alonso MM; Odero MD
    Br J Cancer; 2010 Oct; 103(8):1292-6. PubMed ID: 20842122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos.
    Maki K; Yamagata T; Asai T; Yamazaki I; Oda H; Hirai H; Mitani K
    Blood; 2005 Sep; 106(6):2147-55. PubMed ID: 15914564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
    Sato T; Goyama S; Kataoka K; Nasu R; Tsuruta-Kishino T; Kagoya Y; Nukina A; Kumagai K; Kubota N; Nakagawa M; Arai S; Yoshimi A; Honda H; Kadowaki T; Kurokawa M
    Oncogene; 2014 Oct; 33(42):5028-38. PubMed ID: 24747972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of EVI1 in normal and leukemic cells.
    Buonamici S; Chakraborty S; Senyuk V; Nucifora G
    Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression.
    Yamazaki H; Suzuki M; Otsuki A; Shimizu R; Bresnick EH; Engel JD; Yamamoto M
    Cancer Cell; 2014 Apr; 25(4):415-27. PubMed ID: 24703906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.
    Yoshimi A; Goyama S; Watanabe-Okochi N; Yoshiki Y; Nannya Y; Nitta E; Arai S; Sato T; Shimabe M; Nakagawa M; Imai Y; Kitamura T; Kurokawa M
    Blood; 2011 Mar; 117(13):3617-28. PubMed ID: 21289308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and domain-specific function of GATA-2 during differentiation of the hematopoietic precursor cells in midgestation mouse embryos.
    Minegishi N; Suzuki N; Yokomizo T; Pan X; Fujimoto T; Takahashi S; Hara T; Miyajima A; Nishikawa S; Yamamoto M
    Blood; 2003 Aug; 102(3):896-905. PubMed ID: 12689939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.
    Watanabe-Okochi N; Yoshimi A; Sato T; Ikeda T; Kumano K; Taoka K; Satoh Y; Shinohara A; Tsuruta T; Masuda A; Yokota H; Yatomi Y; Takahashi K; Kitaura J; Kitamura T; Kurokawa M
    Blood; 2013 May; 121(20):4142-55. PubMed ID: 23547050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2.
    Shimahara A; Yamakawa N; Nishikata I; Morishita K
    J Biol Chem; 2010 May; 285(22):16967-77. PubMed ID: 20363750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.